Venture studioBuilding sustainable mobility innovations.
The City of Mainz highlights media, healthcare, biotechnology, and digital technologies as strong sectors. Biomindz, a municipally owned organization, supports life-science and biotechnology growth in Mainz and its surroundings, and identifies immunology, individualized medicine, oncology, diagnostics, and analytics as local focal areas.
The City of Mainz highlights media, healthcare, biotechnology, and digital technologies as strong sectors. Biomindz, a municipally owned organization, supports life-science and biotechnology growth in Mainz and its surroundings, and identifies immunology, individualized medicine, oncology, diagnostics, and analytics as local focal areas.
JGU’s GUTENBERG innovate advises founders and supports research transfer, patenting and exploitation, and company collaborations. BioNTech says it was founded in Mainz in 2008 and describes a therapeutic focus spanning cancer, infectious diseases, and other serious diseases.
Astellas reported acquiring Ganymed Pharmaceuticals AG in December 2016 for €422 million, with up to €860 million contingent on IMAB362 development. The University Medical Center Mainz says Ganymed became an Astellas Pharma subsidiary in 2017.
Startup ecosystem standing
| Ranking | Edition | Position | Since last edition | Trust | What it measures |
|---|---|---|---|---|---|
| 2025 | #241 | No prior edition | B | Ecosystem, Activity, Finance, Business Climate |
5 organizations with a profile
Venture studioBuilding sustainable mobility innovations.
Venture studioBuilding new companies with visionary builders.
Venture studioFull-service venture studio supporting startups in Germany.
IncubatorSupporting Life Sciences and Biotechnology startups.
InvestorInvesting in climate-positive innovations.
Pick what describes you
Investors based here, and the programs that take teams at your stage.
Get investor introsAccelerators and incubators here see the earliest teams first.
Get startups that fitCampuses and communities are where teams form before anyone funds them.
Start scoutingFrom public sources
The Mainz life-science center documents successive Ganymed, TRON, and BioNTech occupancy at its incubator site.
Source: Über unsStartupBlink lists Mainz at #271 globally and #12 in Germany for September 2026 and names its three score inputs.
Source: Top Startups in MainzAstellas reported a €422 million acquisition of Ganymed, with up to €860 million more contingent on a clinical program.
Source: Astellas Pharma Inc. Annual Report 2017The University Medical Center Mainz says Ganymed became an Astellas subsidiary in 2017.
Source: Spin OffsBiomindz identifies immunology, individualized medicine, oncology, diagnostics, and analytics as local focal areas.
Source: About biomindzBiomindz is municipally owned and supports life-science and biotechnology growth in Mainz and its surroundings.
Source: About biomindzIts best position is #241 in StartupBlink Index (cities) (2025).
1 investor based in Mainz has a profile here: kopa ventures. The real number is higher.
Yes. Mainz has 1 incubator and 3 venture studios on record, including Life Science Zentrum Mainz and Next Mobility Labs.
One university has a profile: Johannes Gutenberg University Mainz.
Superscout Pro
Is this page right?How the research works